Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/22/2012CA2726300A1 5 ht receptor mediated neurogenesis
06/21/2012WO2012083261A1 Blood brain barrier-penetrating oximes for cholistenerases reactivation
06/21/2012WO2012083246A1 Novel n- (4- (azetidine - 1 - carbonyl) phenyl) - (hetero - ) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
06/21/2012WO2012083224A1 Bicyclic triazole and pyrazole lactams as allosteric modulators of mglur5 receptors
06/21/2012WO2012083201A1 Steroid tetrol solid state forms-2
06/21/2012WO2012083190A1 Insect odorant receptor antagonists
06/21/2012WO2012083181A1 Alpha helix mimetics and methods for using
06/21/2012WO2012083170A1 Anti-viral compounds
06/21/2012WO2012083164A1 Anti-viral compounds
06/21/2012WO2012083161A1 Steroid tetrol solid state forms
06/21/2012WO2012083145A1 Glucosamine derivatives
06/21/2012WO2012083138A2 Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
06/21/2012WO2012083122A1 Inhibitors of influenza viruses replication
06/21/2012WO2012083121A1 Inhibitors of influenza viruses replication
06/21/2012WO2012083117A1 Inhibitors of influenza viruses replication
06/21/2012WO2012083112A2 Cyp11b, cyp17, and/or cyp21 inhibitors
06/21/2012WO2012083105A1 Inhibitors of hepatitis c virus polymerase
06/21/2012WO2012083061A2 Anti-viral compounds
06/21/2012WO2012083059A1 Anti-viral compounds
06/21/2012WO2012083058A2 Anti-viral compounds
06/21/2012WO2012083053A2 Anti-viral compounds
06/21/2012WO2012083048A2 Anti-viral compounds
06/21/2012WO2012083043A1 Anti-viral compounds
06/21/2012WO2012083034A1 Modulation of neurotrophic factors by omega-3 fatty acid formulations
06/21/2012WO2012082997A1 Tricyclic pi3k inhibitor compounds and methods of use
06/21/2012WO2012082992A1 Compositions and methods for cancer treatment
06/21/2012WO2012082972A1 Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine
06/21/2012WO2012082947A1 Compounds and compositions as tgr5 agonists
06/21/2012WO2012082903A2 Treatment of cognitive impairment in a subject with a neurological autoimmune disease
06/21/2012WO2012082862A2 Androgen receptor inhibitors and methods of use thereof
06/21/2012WO2012082841A2 Universal anti-tag chimeric antigen receptor-expressing t cells and methods of treating cancer
06/21/2012WO2012082817A1 Biarylamide inhibitors of leukotriene production
06/21/2012WO2012082771A1 Cardiac glycosides for treating autoimmune disease
06/21/2012WO2012082718A2 3-methanesulfonylpropionitrile for treating inflammation and pain
06/21/2012WO2012082689A1 SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS
06/21/2012WO2012082635A1 Synthetic oligosaccharide group a streptococcus
06/21/2012WO2012082633A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
06/21/2012WO2012082568A1 Phosphorous derivatives as chemokine receptor modulators
06/21/2012WO2012082566A1 Sulfur derivatives as chemokine receptor modulators
06/21/2012WO2012082470A2 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer
06/21/2012WO2012082436A2 Modulators of histone methyltransferase, and methods of use thereof
06/21/2012WO2012082083A1 Pharmaceutical formulation containing tetrahydrolipstatin as an active ingredient
06/21/2012WO2012082014A2 "mitsephosphon" pharmaceutical composition for stimulating the regeneration of supporting tissues
06/21/2012WO2012082013A2 "mitseostin" pharmaceutical composition for stimulating the regeneration of supporting tissue and articular cartilage (embodiments)
06/21/2012WO2012081944A2 Dental membrane and method of manufacturing the same
06/21/2012WO2012081908A2 Rna aptamer for teiocoic acid in staphylococcus aureus
06/21/2012WO2012081907A2 Rna aptamer for e. coli o157:h7 strain
06/21/2012WO2012081906A2 Rna aptamer for binding to ompc protein in salmonella tiphimirium strain
06/21/2012WO2012081905A2 Pharmaceutical composite formulation comprising hmg-coa reductase inhibitor and aspirin
06/21/2012WO2012081893A2 Novel 3-indolinone derivative and composition having same
06/21/2012WO2012081736A1 Continuous arycyclic compound
06/21/2012WO2012081713A1 Therapeutic agent for blood-brain barrier disruption syndrome
06/21/2012WO2012081692A1 Pyrazole derivative
06/21/2012WO2012081673A1 Ophthalmic composition for contact lens
06/21/2012WO2012081665A1 Substance capable of inhibiting glycine transporter
06/21/2012WO2012081604A1 Composition containing orotic acid, and process for production thereof
06/21/2012WO2012081570A1 Lactam compound or a salt thereof, and ppar activator
06/21/2012WO2012081563A1 Benzothiazole and azabenzothiazole derivative having endothelial lipase inhibitory activity
06/21/2012WO2012081531A1 Disease inhibiting agent
06/21/2012WO2012081370A1 Inhibitor of activity of endothelin, and skin whitening agent
06/21/2012WO2012081273A1 Disease inhibiting agent
06/21/2012WO2012081039A1 Molecules with anticancer activity and uses thereof
06/21/2012WO2012081032A1 Process for the preparation of tenofovir
06/21/2012WO2012080990A1 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
06/21/2012WO2012080986A1 Process for preparing nanoparticles of two polyamino acids of opposite charge, one of the two of which is in charge surplus
06/21/2012WO2012080982A2 Functional food preparation and use thereof
06/21/2012WO2012080976A1 Lar protein-specific ligand
06/21/2012WO2012080953A1 Compounds useful for treating aids
06/21/2012WO2012080952A1 Composition containing resveratrol, l-tryptophan, l-aspartic acid and vitamin b3 for use in the pharmaceutical, nutritional and cosmetic fields
06/21/2012WO2012080882A1 Solid compositions containing nonsteroidal anti-inflammatory drugs, the processes for their preparation and their use.
06/21/2012WO2012080831A1 Composition for the treatment of metabolic disorders
06/21/2012WO2012080803A1 Composition usable in the treatment of cellular degeneration
06/21/2012WO2012080762A1 Novel inhibitors of matrix metalloproteinases
06/21/2012WO2012080735A1 Ask1 inhibiting pyrrolopyrimidine derivatives
06/21/2012WO2012080730A1 Purine derivatives
06/21/2012WO2012080729A2 CASEIN KINASE 1δ (CK1δ) INHIBITORS
06/21/2012WO2012080728A1 Imidazo [4, 5 -c] quinolin- 1 -yl derivative useful in therapy
06/21/2012WO2012080727A2 Casein kinase 1delta (ck1delta) inhibitors
06/21/2012WO2012080718A1 Novel pharmaceutical formulation comprising nsaid and cyclodextrin
06/21/2012WO2012080703A1 Pharmaceutical composition comprising imatinib
06/21/2012WO2012080700A1 A composition comprising an antibiotic and a dispersant or an anti -adhesive agent
06/21/2012WO2012080641A1 S1p receptor agonists and use thereof in treating hiv infections
06/21/2012WO2012080630A1 Novel therapeutic strategies for improving an anticancer treatment
06/21/2012WO2012080555A1 Hydroxytyrosol ethers
06/21/2012WO2012080554A1 Use of antioxidants for the treatment of cognitive and behavioural disorders in individuals with fragile x syndrome
06/21/2012WO2012080519A1 Use of vitamin k for weight maintenance and weight control
06/21/2012WO2012080509A1 Nucleic acids targeting tctp for use in the treatment of chemo-or hormone-resistant cancers
06/21/2012WO2012080503A1 The abcg1 gene as a marker and a target gene for treating obesity
06/21/2012WO2012080497A2 Methods of treatment and prevention of eye diseases
06/21/2012WO2012080476A1 Fused dihydropyrans as gpr119 modulators for the treatment of diabetes, obesity and related diseases
06/21/2012WO2012080466A2 Ingenols for treating seborrheic keratosis
06/21/2012WO2012080461A1 Mirnas in joint disease
06/21/2012WO2012080460A1 Mirnas in joint disease
06/21/2012WO2012080459A1 Mirnas in joint disease
06/21/2012WO2012080457A1 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
06/21/2012WO2012080456A1 Bicyclic ring system substituted amide functionalised phenols as medicaments
06/21/2012WO2012080451A1 Imidazopyridines as respiratory syncytial virus antiviral agents
06/21/2012WO2012080450A1 Azaindoles as respiratory syncytial virus antiviral agents
06/21/2012WO2012080449A1 Azabenzimidazoles as respiratory syncytial virus antiviral agents
06/21/2012WO2012080447A1 Indoles as respiratory syncytial virus antiviral agents
1 ... 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 ... 7860